We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
LABETALOL RMB, LABETALOL SXP, LABETALOL TLB (Southern Cross Pharma Pty Ltd)
Product name
LABETALOL RMB, LABETALOL SXP, LABETALOL TLB
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
248 working days (255)
Active ingredients
labetalol hydrochloride
Registration type
EOI
Indication
LABETALOL RMB, LABETALOL SXP, LABETALOL TLB (solution for injection) is indicated for the emergency treatment of severe hypertension when prompt and urgent reduction of blood pressure is essential.